Sign in

    Bradford Seagraves

    Research Analyst at North Bank Capital

    Bradford Seagraves is the Founder and Chief Investment Officer at Northbank Capital Management, specializing in equity research and investment across diverse sectors with a notable focus on healthcare companies such as Nutex Health. He has experience engaging directly with company management during earnings calls and has previously held analyst and research roles at firms like Davenport and Bank of America Merrill Lynch. Seagraves launched Northbank Capital Management in 2021 and leverages over a decade of industry expertise. As a CFA charterholder, he is recognized for his rigorous investment analysis and commitment to professional excellence.

    Bradford Seagraves's questions to Nutex Health (NUTX) leadership

    Bradford Seagraves's questions to Nutex Health (NUTX) leadership • Q2 2025

    Question

    Bradford Seagraves requested commentary on business performance and free cash flow trends quarter-to-date in Q3 and asked if the company planned to publish unaudited Q2 financial statements ahead of the full restated filing.

    Answer

    CFO John Bates indicated that the strong and consistent operational trends seen in the first half of 2025 have continued into Q3 but did not provide specific figures. He explained that while the company will consider providing more data, the immediate focus is on the restatement process, which primarily impacts non-cash items and does not change the business's strong fundamentals.

    Ask Fintool Equity Research AI